ARPEGGIO BIO
Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action. The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and how therapeutics work.
ARPEGGIO BIO
Industry:
Biotechnology Health Care Machine Learning Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.arpeggiobio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
20.35 M USD
Technology used in webpage:
U.S. Server Location Pound Sterling Japanese Yen
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Enveda Biosciences
Enveda Biosciences is a biotechnology company building new medicines from plants.
Foresight Diagnostics
Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
Jio Health
Jio Health tracks vitals, manages medications, and connects with providers and caregivers in meaningful ways.
SonarMD
SonarMD provides care management for complex chronic conditions that use high-cost drugs.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Turning Point Therapeutics
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
TechU Ventures
TechU Ventures investment in Series A - Arpeggio Bio
ATEM Capital Fund LP
ATEM Capital Fund LP investment in Series A - Arpeggio Bio
Milad Alucozai
Milad Alucozai investment in Series A - Arpeggio Bio
Builders VC
Builders VC investment in Series A - Arpeggio Bio
Fifty Years
Fifty Years investment in Series A - Arpeggio Bio
Formic Ventures
Formic Ventures investment in Series A - Arpeggio Bio
FundersClub
FundersClub investment in Series A - Arpeggio Bio
Matt De Silva
Matt De Silva investment in Series A - Arpeggio Bio
Alice Zhang
Alice Zhang investment in Series A - Arpeggio Bio
Khosla Ventures
Khosla Ventures investment in Series A - Arpeggio Bio
Official Site Inspections
http://www.arpeggiobio.com Semrush global rank: 9.08 M Semrush visits lastest month: 445
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Arpeggio Bio"
About Us - Arpeggio Bio
Arpeggio is a team of computer scientists, biologists, and entrepreneurs using functional genomics to find new therapeutic targets for hard to treat diseases like cancer.See details»
Arpeggio Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.See details»
Arpeggio Bio - Org Chart, Teams, Culture & Jobs - The …
View Arpeggio Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Arpeggio Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.arpeggiobio.com. Startups | Holding Company | 2017 | Colorado, United States | 10-50 | www.arpeggiobio.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Arpeggio Company Profile 2024: Valuation, Funding & Investors
Arpeggio General Information Description. Developer of a drug assessment technology designed to study mechanistic understanding of how drugs work. The company's platform combines its …See details»
Arpeggio Bio - Y Combinator Startup | YC Batch S19
Learn about Arpeggio Bio, a Y Combinator startup from the S19 batch. Offering innovative solutions in with a team size of 20.See details»
Arpeggio Bio - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... arpeggiobio.com. Company …See details»
Arpeggio Biosciences, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Arpeggio Biosciences, Inc. of Boulder, CO. Get the latest business insights from Dun & Bradstreet.See details»
Arpeggio Bio
Arpeggio is developing the world's fastest platform for transcriptomic sequencing to learn how chemistry maps to network biology.See details»
Arpeggio Bio Company Profile: AI, Investments, Contact …
Arpeggio Bio is a biotech startup fighting drug resistance in cancer. Our automated laboratory profiles thousands of drugs for changes in RNA and uses AI to uncover how cancer evades …See details»
Arpeggio Biosciences - Craft
Arpeggio Biosciences has 5 employees at their 1 location and $3.35 m in total funding,. See insights on Arpeggio Biosciences including office locations, competitors, revenue, financials, …See details»
Arpeggio Biosciences CEO and Key Executive Team | Craft.co
Arpeggio Biosciences's Co-Founder, CEO is Joey Azofeifa. Other executives include Laura Norris, COO & Co-Founder; Tim Read, CTO & Co-Founder. See the full leadership team at Craft.See details»
Careers - Arpeggio Bio
Arpeggio is a team of computer scientists, biologists, and entrepreneurs using functional genomics to find new therapeutic targets for hard to treat diseases like cancer.See details»
Arpeggio Bio Raises $3.2 Million in Seed Funding and CEO
Jan 15, 2020 BOULDER, Colo.--(BUSINESS WIRE)-- Arpeggio Bio, a preclinical company whose technology provides a mechanistic understanding of how drugs work, today announced …See details»
Arpeggio Biosciences Raises $17 Million in Series A Funding Led …
Sep 7, 2022 Arpeggio Biosciences, a preclinical therapeutics company whose technology targets transcriptional dysregulation in disease, and Builders VC, today annSee details»
Technology - Arpeggio Bio
Every cell in our body has the same genome, but a hair follicle looks a lot different than a neuron. This is due to a cell’s transcriptome: the set of more than 20,000 mRNAs uniquely oriented to …See details»
Arpeggio Blog
Arpeggio Blog Musings about science, startups, and mathematics. Dynamic Transcriptomics Watching Transcriptomics. Posted by Joey Azofeifa on June 1st, 2020See details»
News - Arpeggio Bio
This Nature paper from Kim et al. illuminates a really exciting mechanism underpinning chronic kidney disease and ferroptosis. In patients with type 2 diabetes, nephrons had significantly …See details»
Pipeline - Arpeggio Bio
Most pharmaceutical companies consider transcription factors “undruggable” even though they play critical roles in cancer, chronic kidney disease, and neurodegeneration.See details»